Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome
CYLD cutaneous syndrome (also known as Brooke-Spiegler syndrome) is characterised by germline mutations in the tumor suppressor CYLD. Here, the authors highlight recurrent mutations in DNMT3A and BCOR, indicating a role for epigenetic dysregulation in this rare genetic skin disease.
Guardado en:
Autores principales: | Helen R. Davies, Kirsty Hodgson, Edward Schwalbe, Jonathan Coxhead, Naomi Sinclair, Xueqing Zou, Simon Cockell, Akhtar Husain, Serena Nik-Zainal, Neil Rajan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/455161ea0e7d48609e0545f51dafe8d6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis
por: Madison J. Kelly, et al.
Publicado: (2019) -
Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth Syndrome
por: Amanda M. Smith, et al.
Publicado: (2021) -
Rare CYLD Variants in Chinese Patients With Amyotrophic Lateral Sclerosis
por: Xiaojing Gu, et al.
Publicado: (2021) -
The tumour suppressor CYLD regulates the p53 DNA damage response
por: Vanesa Fernández-Majada, et al.
Publicado: (2016) -
Epigenetic interaction between UTX and DNMT1 regulates diet-induced myogenic remodeling in brown fat
por: Fenfen Li, et al.
Publicado: (2021)